In melanoma xenograft models, Snail1 transfectants (or cells expressing Snail1 following TGF‐β treatment) acquire EMT features and this results in a shorter overall survival of mice (Kudo‐Saito et al., 2009). This evidence concerns the gene SNAI1 and melanoma.